| <20 years | |||||||||
|
| n = 60 (%) | 5-Year OS* (%) | pa | 10-Year OS* (%) | pa | 5-Year EFS† (%) | pa | 10-Year EFS† (%) | pa |
| Metastasis |
|
| 0.028 |
| 0.399 |
| 0.001 |
| 0.115 |
| Localized | 52 (86.7) | 42 (79.9) |
| 18 (34.6) |
| 40 (76.9) |
| 18 (34.6) |
|
| Metastasis(+) | 8 (13.3) | 3 (37.5) |
| 1 (12.5) |
| 1 (12.5) |
| 0 (0.0) |
|
| 20 - 40 Years | |||||||||
|
| n = 290 (%) | 5-Year OS* (%) | pa | 10-Year OS* (%) | pa | 5-Year EFS† (%) | pa | 10-Year EFS† (%) | pa |
| Metastasis |
|
| 0.002 |
| <0.001 |
| <0.001 |
| <0.001 |
| Localized | 197 (67.9) | 151 (76.7) |
| 104 (52.8) |
| 155 (78.7) |
| 104 (52.8) |
|
| Metastasis(+) | 93 (32.1) | 35 (37.6) |
| 17 (18.3) |
| 15 (16.1) |
| 8 (8.6) |
|
| ≥40 Years | |||||||||
|
| n = 29 (%) | 5-Year OS* (%) | pa | 10-Year OS* (%) | pa | 5-Year EFS† (%) | pa | 10-Year EFS† (%) | pa |
| Metastasis |
|
| 0.455 |
| 0.874 |
| 0.028 |
| 0.310 |
| Localized | 23 (79.3) | 14 (60.9) |
| 7 (30.4) |
| 14 (60.9) |
| 7 (30.4) |
|
| Metastasis(+) | 6 (20.7) | 2 (33.3) |
| 1 (16.7) |
| 0 (0.0) |
| 0 (0.0) |
|